| Patents for A61P 27 - Drugs for disorders of the senses (53,017) |
|---|
| 06/03/2004 | US20040106604 Novel pyrrole derivatives as pharmaceutical agents |
| 06/03/2004 | US20040106597 Novel fused indazoles and indoles and their use for the treatment of glaucoma |
| 06/03/2004 | US20040106580 Omega-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 06/03/2004 | US20040106558 Hydroxamate-containing cysteine and serine protease inhibitors |
| 06/03/2004 | US20040106546 comprises cyclosporin, hyaluronic acid, and polysorbate compound |
| 06/03/2004 | US20040106196 Systems and methods for treating patients with processed lipoaspirate cells |
| 06/02/2004 | EP1424335A1 Indole derivatives |
| 06/02/2004 | EP1424326A1 Fused-polycyclic compounds |
| 06/02/2004 | EP1424325A1 Indole derivatives, process for producing the same and drugs containing the same as the active ingredient |
| 06/02/2004 | EP1424081A1 Polysaccharide-containing compositions and use thereof |
| 06/02/2004 | EP1423697A2 Secreted proteins |
| 06/02/2004 | EP1423511A2 Nucleic-acid associated proteins |
| 06/02/2004 | EP1423428A2 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 06/02/2004 | EP1423422A2 A caspase- 8 binding protein, its preparation and use |
| 06/02/2004 | EP1423406A2 Rna interference mediated inhibition of gene expression using short interfering nucleic acid (sina) |
| 06/02/2004 | EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors |
| 06/02/2004 | EP1423380A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 06/02/2004 | EP1423132A2 Complex mixtures exhibiting selective inhibition of cyclooxygenase-2 |
| 06/02/2004 | EP1423126A2 Treatment of hyperproliferative conditions of body surfaces |
| 06/02/2004 | EP1423125A1 Use of non-feminizing estrogens as retinoprotective agents for the treatment of glaucoma |
| 06/02/2004 | EP1423119A1 Heterobicycles fkbp-ligands |
| 06/02/2004 | EP1423115A2 Synthesis and anti-tumor activity of nitrogen substituted thalidomide analogs |
| 06/02/2004 | EP1244614B1 Tryptase inhibitors |
| 06/02/2004 | EP1096943B1 Method of preparation and pharmaceutical composition of an uncaria water soluble extract |
| 06/02/2004 | CN1501937A Spiro-pyrimidine-2,4,6-trione metalloproteinase inhibitors |
| 06/02/2004 | CN1501931A Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501930A Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists |
| 06/02/2004 | CN1501915A Bipiperidinyl-derivatives and their use as chemokine receptor inhibitors |
| 06/02/2004 | CN1501911A Phenethanolamine derivatives for treatment of respiratory diseases |
| 06/02/2004 | CN1501827A Ligands of the alpha-v-beta 6 integrin |
| 06/02/2004 | CN1501813A Visual function improving agents |
| 06/02/2004 | CN1501798A Medicinal compositions comprising diclofenac and ornoprostil |
| 06/02/2004 | CN1501795A Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 06/02/2004 | CN1500494A Compound formulation for myopia, hypermetropia, strabismus and amblyopia |
| 06/02/2004 | CN1152014C N-aryl anthranilic acid derivatives and uses thereof |
| 06/02/2004 | CN1151794C Medicinal compositions for treating eye diseases |
| 06/02/2004 | CN1151775C Method of treating dry eye disease with purinergic receptor agonists |
| 06/01/2004 | US6743810 Indol-3-yl derivatives |
| 06/01/2004 | US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α |
| 06/01/2004 | US6743802 Alkyne-aryl phosphodiesterase-4 inhibitors |
| 06/01/2004 | US6743800 Vitronectin receptor antagonists and inhibitors of cell adhesion; osteoporosis, angiogenesis inhibitors |
| 06/01/2004 | US6743792 Antiinflammatory agents |
| 06/01/2004 | US6743428 Angiogenesis inhibitor |
| 05/27/2004 | WO2004043933A1 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | WO2004043932A1 Ophthalmic compositions for treating ocular hypertension |
| 05/27/2004 | WO2004043480A2 Intraocular administration of cyclosporin a for the treatment of macular degeneration, retinopathy or retinitis pigmentosa |
| 05/27/2004 | WO2004043470A1 The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| 05/27/2004 | WO2004043447A2 Compositions and methods for treating or preventing hearing impairment |
| 05/27/2004 | WO2004004725A3 Pharmaceutical compositions of anticholinergics and p38 kinase inhibitors in the treatment of respiratory diseases |
| 05/27/2004 | WO2003095637B1 Combination of a growth factor and a protease enzyme |
| 05/27/2004 | WO2003073986A3 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 05/27/2004 | WO2003059276B1 Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
| 05/27/2004 | WO2003011262A3 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 05/27/2004 | WO2003006002A8 Compositions and methods of administering tubulin binding agents for the treatment of ocular diseases |
| 05/27/2004 | WO2002102854A3 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 05/27/2004 | WO2002092063A3 Utilization of rutins and aescins in the treatment of ocular circulatory disturbances |
| 05/27/2004 | WO2002080857A8 Polymorphs of fexofenadine hydrochloride |
| 05/27/2004 | WO2000073764A3 Composition and methods for the therapeutic use of an atonal-associated sequence |
| 05/27/2004 | US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis |
| 05/27/2004 | US20040102527 Use of cyclohexenone derivatives in the manufacture of a medicament for treating diabetic complications |
| 05/27/2004 | US20040102508 Naphathalene derivatives which bind to the ep4 receptor |
| 05/27/2004 | US20040102460 Phosphodiesterase 4 inhibitors |
| 05/27/2004 | US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents |
| 05/27/2004 | US20040102445 Synergistic mixture; hypotensive agents for eyes |
| 05/27/2004 | US20040102441 Ortho-substituted anthranilic acid amides and their use as medicaments |
| 05/27/2004 | US20040102438 Gaba-receptor modulators for the treatment of neurodegenerative diseases of the eye |
| 05/27/2004 | US20040102432 Asthma, rhinitis therapy |
| 05/27/2004 | US20040102418 Compounds for the treatment of inflammatory disorders |
| 05/27/2004 | US20040102379 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 05/27/2004 | US20040101882 Secreted proteins |
| 05/27/2004 | CA2504200A1 The use of an anti-allergy agent and a steroid to treat allergic rhinitis |
| 05/26/2004 | EP1422292A1 Fermentation product of cyptoporus volvatus and its preparation method and use |
| 05/26/2004 | EP1422217A2 Aminocyclohexyl ether compounds and uses thereof |
| 05/26/2004 | EP1421974A1 Carboxy methyl beta-1, 3 glucan containing ophthalmic solution |
| 05/26/2004 | EP1421948A2 Use of botulinum toxins for treating sweating in humans |
| 05/26/2004 | EP1421935A1 Thiourea carbonic anhydrase inhibitors and their use in treatment of glaucoma |
| 05/26/2004 | EP1421190A2 Metabolic gene polynucleotides and polypeptides and uses thereof |
| 05/26/2004 | EP1421108A2 Antimicrobial and anti-inflammatory peptides |
| 05/26/2004 | EP1421084A1 Polycyclic guanine phosphodiesterase v inhibitors |
| 05/26/2004 | EP1421082A1 New piperidinyl-morpholinyl derivatives as modulators of chemokine receptor activity |
| 05/26/2004 | EP1420831A1 Lipid constructs as therapeutic and imaging agents |
| 05/26/2004 | EP1420817A1 Moraxella (branhamella) catarrhalis polypeptides and corresponding dna fragments |
| 05/26/2004 | EP1420797A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 05/26/2004 | EP1420793A1 Method and composition for treatment of ocular hypertension and glaucoma |
| 05/26/2004 | EP1420791A1 Use of compounds for treating conditions resulting from injury to the corneal nerve after lasik and other ocular surgeries or trauma |
| 05/26/2004 | EP1420788A1 Novel piperidin-2,6-dione bisulphate salts and their use for the treatment of stress-related affective disorders |
| 05/26/2004 | EP1420787A2 Ophthalmic composition comprising an ascomycin |
| 05/26/2004 | EP1420785A2 SUBSTITUTED INDENO 1,2-c]ISOQUINOLINE DERIVATIVES AND METHODS OF USE THEREOF |
| 05/26/2004 | EP1420783A1 Stable emulsion composition |
| 05/26/2004 | EP1420774A1 Preparation and diabetic use of gibberellins |
| 05/26/2004 | EP1420772A2 Use of beta-adrenoceptor agonists for the treatment of neurodegenerative diseases |
| 05/26/2004 | EP1420760A2 Aerosolized decongestants for the treatment of sinusitis |
| 05/26/2004 | EP1420745A2 Use of r-nsaid compounds for anti-hiv treatment |
| 05/26/2004 | EP1420716A1 An implantable and sealable system for unidirectional delivery of therapeutic agents to targeted tissues |
| 05/26/2004 | EP1296996B1 Purine derivatives |
| 05/26/2004 | EP1257553B1 Pyrrolopyrimidinone derivatives, process of preparation and use |
| 05/26/2004 | EP1216245B1 Pharmaceutically active sulfonyl hydrazide derivatives |
| 05/26/2004 | EP1124815B1 Method for producing luteolin and luteolin derivatives |
| 05/26/2004 | EP1069885B1 Ophthalmic solution comprising glycogen |
| 05/26/2004 | EP1027332B1 Novel lactam metalloprotease inhibitors |